DNA Microarrays: a Powerful Genomic Tool for Biomedical and Clinical Research

Among the many benefits of the Human Genome Project are new and powerful tools such as the genome-wide hybridization devices referred to as microarrays. Initially designed to measure gene transcriptional levels, microarray technologies are now used for comparing other genome features among individuals and their tissues and cells. Results provide valuable information on disease subcategories, disease prognosis, and treatment outcome. Likewise, they reveal differences in genetic makeup, regulatory mechanisms, and subtle variations and move us closer to the era of personalized medicine. To understand this powerful tool, its versatility, and how dramatically it is changing the molecular approach to biomedical and clinical research, this review describes the technology, its applications, a didactic step-by-step review of a typical microarray protocol, and a real experiment. Finally, it calls the attention of the medical community to the importance of integrating multidisciplinary teams to take advantage of this technology and its expanding applications that, in a slide, reveals our genetic inheritance and destiny.

[1]  Ash A. Alizadeh,et al.  Genome-wide analysis of DNA copy-number changes using cDNA microarrays , 1999, Nature Genetics.

[2]  R. Tibshirani,et al.  Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Andrea Ferreira-Gonzalez,et al.  Genome-wide detection of LOH in prostate cancer using human SNP microarray technology. , 2003, Genomics.

[4]  Patrick Tan,et al.  Genetic algorithms applied to multi-class prediction for the analysis of gene expression data , 2003, Bioinform..

[5]  A. Syvänen.  Toward genome-wide SNP genotyping , 2005, Nature Genetics.

[6]  L. Staudt,et al.  The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.

[7]  Michał Jankowski,et al.  Microarray‐based survey of CpG islands identifies concurrent hyper‐ and hypomethylation patterns in tissues derived from patients with breast cancer , 2006, Genes, chromosomes & cancer.

[8]  Andreas Rytz,et al.  Microarray data analysis: a practical approach for selecting differentially expressed genes , 2001, Genome Biology.

[9]  P. Brown,et al.  Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Lawrence B. Gardner,et al.  c-myc Protooncogene , 2002 .

[11]  W. Liang,et al.  TM4 microarray software suite. , 2006, Methods in enzymology.

[12]  Christoph Plass,et al.  ChIP-chip comes of age for genome-wide functional analysis. , 2006, Cancer research.

[13]  Marina Vannucci,et al.  Bayesian Variable Selection in Multinomial Probit Models to Identify Molecular Signatures of Disease Stage , 2004, Biometrics.

[14]  A. Orth,et al.  Large-scale analysis of the human and mouse transcriptomes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Anoop Grewal,et al.  Tools for Analyzing Microarray Expression Data , 2000 .

[16]  Bernhard O. Palsson,et al.  Cancer cell lines , 1999 .

[17]  U. Alon,et al.  Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Michael Rehli,et al.  Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. , 2006, Cancer research.

[19]  Jutta Heim,et al.  Comparative microarray analysis of gene expression during apoptosis-induction by growth factor deprivation or protein kinase C inhibition , 2000, Oncogene.

[20]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[21]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[22]  W. Liang,et al.  9) TM4 Microarray Software Suite , 2006 .

[23]  A. Bird.  CpG-rich islands and the function of DNA methylation , 1986, Nature.

[24]  Kevin L. Gunderson,et al.  Highly parallel genomic assays , 2006, Nature Reviews Genetics.

[25]  Sandya Liyanarachchi,et al.  Prognostic DNA Methylation Biomarkers in Ovarian Cancer , 2006, Clinical Cancer Research.

[26]  Jason E. Stewart,et al.  Minimum information about a microarray experiment (MIAME)—toward standards for microarray data , 2001, Nature Genetics.

[27]  Diana Blaydon,et al.  Genomewide single nucleotide polymorphism microarray mapping in basal cell carcinomas unveils uniparental disomy as a key somatic event. , 2005, Cancer research.

[28]  Paul Cairns,et al.  Genome-wide genetic characterization of bladder cancer: a comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis. , 2003, Cancer research.

[29]  J. Derisi,et al.  Microarray-based detection and genotyping of viral pathogens , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Jason E. Stewart,et al.  Design and implementation of microarray gene expression markup language (MAGE-ML) , 2002, Genome Biology.

[31]  Mona Prasad,et al.  Large scale copy number variation (CNV) at 14q12 is associated with the presence of genomic abnormalities in neoplasia , 2006, BMC Genomics.

[32]  A Chakravarti,et al.  High-throughput variation detection and genotyping using microarrays. , 2001, Genome research.

[33]  M You,et al.  Gene expression signatures identify novel regulatory pathways during murine lung development: implications for lung tumorigenesis , 2003, Journal of medical genetics.

[34]  Trey Ideker,et al.  Integrated Assessment and Prediction of Transcription Factor Binding , 2006, PLoS Comput. Biol..

[35]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Kathleen Marchal,et al.  Advances in Cluster Analysis of Microarray Data , 2005, Data Analysis and Visualization in Genomics and Proteomics.

[37]  T. Poggio,et al.  Multiclass cancer diagnosis using tumor gene expression signatures , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Jutta Heim,et al.  A microarray-based, integrated approach to identify novel regulators of cancer drug response and apoptosis , 2002, Oncogene.

[39]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[40]  Lukasz Huminiecki,et al.  Congruence of tissue expression profiles from Gene Expression Atlas, SAGEmap and TissueInfo databases , 2003, BMC Genomics.

[41]  Francesco Falciani,et al.  GALGO: an R package for multivariate variable selection using genetic algorithms , 2006, Bioinform..

[42]  S. Altschul,et al.  SAGEmap: a public gene expression resource. , 2000, Genome research.

[43]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[44]  H A Barrera-Saldaña,et al.  Transcriptional products of the human placental lactogen gene. , 1982, The Journal of biological chemistry.

[45]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[46]  John D. Storey.  A direct approach to false discovery rates , 2002 .

[47]  C. M. Chen,et al.  Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. , 2001, Cancer research.

[48]  James E. Allen,et al.  T1DBase: integration and presentation of complex data for type 1 diabetes research , 2006, Nucleic Acids Res..

[49]  R. Nuttall,et al.  An evaluation of the performance of cDNA microarrays for detecting changes in global mRNA expression. , 2001, Nucleic acids research.

[50]  E. Lander,et al.  Gene expression correlates of clinical prostate cancer behavior. , 2002, Cancer cell.

[51]  John Quackenbush,et al.  Genesis: cluster analysis of microarray data , 2002, Bioinform..

[52]  Joachim Diebold,et al.  Functional epigenomics identifies genes frequently silenced in prostate cancer. , 2005, Cancer research.

[53]  S Henikoff,et al.  Exploring and explaining epigenetic effects. , 1997, Trends in genetics : TIG.

[54]  Cheryl Schmidt,et al.  Identification of genes differentially over-expressed in lung squamous cell carcinoma using combination of cDNA subtraction and microarray analysis , 2000, Oncogene.

[55]  Yan Wang,et al.  Microarray-based molecular margin methylation pattern analysis in colorectal carcinoma. , 2006, Analytical biochemistry.

[56]  Francesco M Marincola,et al.  Infectious pathogen detection arrays: viral detection in cell lines and postmortem brain tissue. , 2005, BioTechniques.

[57]  Thomas A. Darden,et al.  Gene selection for sample classification based on gene expression data: study of sensitivity to choice of parameters of the GA/KNN method , 2001, Bioinform..

[58]  G. Getz,et al.  Coupled two-way clustering analysis of gene microarray data. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[59]  V. Beneš,et al.  Alternative Splicing Microarrays Reveal Functional Expression of Neuron-specific Regulators in Hodgkin Lymphoma Cells* , 2005, Journal of Biological Chemistry.

[60]  Joaquín Dopazo,et al.  GEPAS, an experiment-oriented pipeline for the analysis of microarray gene expression data , 2005, Nucleic Acids Res..

[61]  Jae Won Lee,et al.  Comparison of various statistical methods for identifying differential gene expression in replicated microarray data , 2006, Statistical methods in medical research.

[62]  T. Gingeras,et al.  Microarray-based DNA methylation profiling: technology and applications , 2022 .

[63]  P. Laird.  Early detection: The power and the promise of DNA methylation markers , 2003, Nature Reviews Cancer.

[64]  Ozy Sjahputera,et al.  Discovery of novel epigenetic markers in non-Hodgkin's lymphoma. , 2007, Carcinogenesis.

[65]  Hongjuan Zhao,et al.  Genome‐wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines , 2005, The Prostate.

[66]  Moreno Rocha Jc,et al.  [Genetic transcription in eukaryotes: from transcriptional factors to disease]. , 1999 .